Contract 75A50126C00002
Vericel Corporation · Department Of Health And Human Services · April 1, 2026
Vericel Corporation was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on April 1, 2026 for $34.88 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Cambridge, MA. It was awarded under full and open competition. It uses cost-plus contract pricing. If all options are exercised, the contract could reach $191.78 million.
Contract details
- PIID
- 75A50126C00002
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Surgical Dressing Materials
- Place of performance
- Cambridge, MA
- First action
- April 1, 2026
Description
NON SURGICAL DEBRIDEMENT
Modification timeline
-
April 1, 2026Base award$34.88M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 30, 2026 | $493.5K |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50126C00002?
Contract 75A50126C00002 is a federal contract awarded to Vericel Corporation by Department Of Health And Human Services on April 1, 2026 for $34.88 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75A50126C00002?
Vericel Corporation won contract 75A50126C00002 from Department Of Health And Human Services.
How much is contract 75A50126C00002 worth?
Contract 75A50126C00002 has obligated $34.88 million to date, with a total potential value of $191.78 million if all options are exercised.